BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16537683)

  • 1. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.
    Elisei R; Vivaldi A; Ciampi R; Faviana P; Basolo F; Santini F; Traino C; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2389-95. PubMed ID: 16537683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
    Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
    Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
    Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-Allylamino-17-demethoxygeldanamycin and Herbimycin A Induce Cell Death by Modulating β-Catenin and PI3K/AKT Signaling in FRO Anaplastic Thyroid Carcinoma Cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Anticancer Res; 2015 Oct; 35(10):5453-60. PubMed ID: 26408708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid.
    Vivaldi A; Miasaki FY; Ciampi R; Agate L; Collecchi P; Capodanno A; Pinchera A; Elisei R
    Mol Cell Endocrinol; 2009 Aug; 307(1-2):142-8. PubMed ID: 19524134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
    Haberkorn U
    Exp Clin Endocrinol Diabetes; 2001; 109(1):60-2. PubMed ID: 11573143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
    Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
    BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
    Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
    Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
    Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
    J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
    Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
    Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.